Get the Stockscreener App
3.73
1.77%
-0.06
Avita Medical Inc stock is traded at $3.73, with a volume of 207.39K.
It is down -1.77% in the last 24 hours and down -6.22% over the past month.
Avita is a single product company. Its RECELL system is an innovative burn treatment device which creates Spray-on Skin from a small skin sample within 30 minutes, thus avoiding or reducing the need for skin grafts. It's approved for the treatment of adult and paediatric patients in the US and an expanded indication for soft-tissue reconstruction. It is currently in rollout across the approximately 136 US burn centers. Despite having product approval in Australia, Europe, Canada, and China, Avita is not actively marketing in those territories and focussing instead on the US region. However, it is expected to launch in Japan via distribution partner Cosmotec in second-half fiscal 2022. Avita is domiciled, and has its primary listing, in the US.
See More
Previous Close:
$3.79
Open:
$3.76
24h Volume:
207.39K
Relative Volume:
0.37
Market Cap:
$113.74M
Revenue:
$50.14M
Net Income/Loss:
$-35.38M
P/E Ratio:
-2.6643
EPS:
-1.4
Net Cash Flow:
$-39.46M
1W Performance:
-3.55%
1M Performance:
-6.22%
6M Performance:
-40.72%
1Y Performance:
-72.09%
1-Day Range:
$3.64
$3.84
1-Week Range:
$3.64
$4.09
52-Week Range:
$3.35
$14.16
Avita Medical Inc Stock (RCEL) Company Profile
Name
Avita Medical Inc
Sector
Industry
Phone
661-568-1317
Address
28159 AVENUE STANFORD, VALENCIA, CA
Compare RCEL with other stocks
| Stocks | Price | Market Cap | Revenue | Net Income | Cash Flow | EPS |
|---|---|---|---|---|---|---|
RCEL
Avita Medical Inc
|
3.73 | 115.57M | 50.14M | -35.38M | -39.46M | -1.40 |
|
ABT
Abbott Laboratories
|
128.50 | 222.77B | 43.84B | 13.90B | 6.92B | 7.9725 |
|
BSX
Boston Scientific Corp
|
98.12 | 143.62B | 19.35B | 2.78B | 3.82B | 1.8696 |
|
SYK
Stryker Corp
|
370.78 | 140.84B | 24.38B | 2.94B | 4.07B | 7.6159 |
|
MDT
Medtronic Plc
|
103.00 | 129.80B | 34.76B | 4.79B | 5.21B | 3.7049 |
|
EW
Edwards Lifesciences Corp
|
84.70 | 49.40B | 5.88B | 1.34B | 799.60M | 2.3489 |
Avita Medical Inc Stock (RCEL) Upgrades & Downgrades
| Date | Action | Analyst | Rating Change |
|---|---|---|---|
| Nov-20-25 | Upgrade | BTIG Research | Sell → Neutral |
| Aug-08-25 | Downgrade | BTIG Research | Neutral → Sell |
| Dec-24-24 | Initiated | D. Boral Capital | Buy |
| Apr-11-24 | Downgrade | BTIG Research | Buy → Neutral |
| Jun-27-23 | Initiated | Cantor Fitzgerald | Overweight |
| Mar-02-21 | Initiated | Piper Sandler | Overweight |
| Aug-27-20 | Initiated | BofA Securities | Buy |
| Apr-21-20 | Initiated | Oppenheimer | Outperform |
| Mar-03-20 | Initiated | BTIG Research | Buy |
View All
Avita Medical Inc Stock (RCEL) Latest News
Avita Medical (NASDAQ:RCEL) Upgraded at BTIG Research - MarketBeat
Why AVITA Medical Inc. stock is favored by top institutionsJuly 2025 Macro Moves & Free Reliable Trade Execution Plans - newser.com
BTIG Upgrades AVITA Medical (RCEL) - Nasdaq
AVITA Medical Inc (RCEL) Stock News & Articles - 24/7 Wall St.
RCEL Upgraded by BTIG: New Neutral Rating | RCEL Stock News - GuruFocus
BTIG upgrades Avita Medical stock rating to Neutral from Sell By Investing.com - Investing.com Canada
How AVITA Medical Inc. stock performs in high volatility marketsMarket Performance Summary & Fast Exit and Entry Trade Guides - newser.com
Bronstein, Gewirtz & Grossman, LLC Is Investigating AVITA Medical, Inc. (RCEL) And Encourages Investors to Connect - ACCESS Newswire
Will AVITA Medical Inc. stock benefit from commodity pricesMarket Rally & Growth Oriented Trade Recommendations - newser.com
How to escape a deep drawdown in AVITA Medical Inc.2025 Biggest Moves & Daily Stock Trend Watchlist - newser.com
Leading vs lagging indicators on AVITA Medical Inc. performanceJuly 2025 Action & Weekly Top Stock Performers List - newser.com
Bragar Eagel & Squire, P.C. Encourages Agilon, Soleno, - GlobeNewswire
Historical volatility pattern of AVITA Medical Inc. visualizedMarket Growth Review & Free Fast Gain Swing Trade Alerts - newser.com
Q2 2025 AVITA Medical Inc Earnings Call Transcript - GuruFocus
Is AVITA Medical Inc. stock attractive for income investors2025 Price Action Summary & High Return Trade Guides - newser.com
Avita Medical Inc. (NASDAQ:RCEL) Given Average Rating of "Reduce" by Brokerages - MarketBeat
Why AVITA Medical Inc. stock remains a top recommendationWeekly Trade Report & Community Verified Trade Alerts - newser.com
How AVITA Medical Inc. stock performs during Fed tightening cycles2025 EndofYear Setup & Consistent Income Trade Recommendations - newser.com
How AVITA Medical Inc. stock performs in weak economyWeekly Market Report & Comprehensive Market Scan Reports - newser.com
How analysts rate AVITA Medical Inc. stock todayJuly 2025 Decliners & Weekly Market Pulse Updates - newser.com
Bronstein, Gewirtz & Grossman, LLC Is Investigating AVITA Medical, Inc. (RCEL) And Encourages Shareholders to Connect - ACCESS Newswire
What analysts say about AVITA Medical Inc stockDividend Stability Analysis & Free High Frequency Trading Ideas - earlytimes.in
Brokers Offer Predictions for Avita Medical FY2025 Earnings - MarketBeat
How AVITA Medical Inc. stock performs in interest rate cyclesQuarterly Portfolio Report & AI Powered Market Entry Strategies - newser.com
Bronstein, Gewirtz & Grossman, LLC Initiates an Investigation into Allegations Against AVITA Medical, Inc. (RCEL) And Encourages Shareholders to Reach Out - ACCESS Newswire
AVITA Medical (RCEL) Q3 2025 Earnings Transcript - AOL.com
Bronstein, Gewirtz & Grossman, LLC Announces an Investigation Against AVITA Medical, Inc. (RCEL) and Encourages Shareholders to Learn More About the Investigation - ACCESS Newswire
Bragar Eagel & Squire, P.C. Is Investigating Agilon, - GlobeNewswire
AVITA Medical Hits 52-Week Low at $3.37 Amidst Significant Decline - Markets Mojo
AVITA Medical Hits 52-Week Low at $3.35 Amid Significant Decline - Markets Mojo
Using AI based signals to follow AVITA Medical Inc.July 2025 Snapshot & High Accuracy Trade Alerts - newser.com
Is AVITA Medical Inc. stock a top pick in earnings seasonTrade Entry Report & Entry Point Strategy Guides - newser.com
Avita signals revenue recovery with $70M–$74M 2025 outlook following reimbursement clarity - MSN
How Volatile Is Azad Engineering Limited Compared to PeersMarket Liquidity Analysis & Access Risk Ratings for Every Stock - earlytimes.in
AVITA Medical to Host Investor Webinar Briefing - The Manila Times
Avita Medical Inc Stock (RCEL) Financials Data
Revenue
Net Income
Cash Flow
EPS
Avita Medical Inc Stock (RCEL) Insider Trading
| Insider Trading | Relationship | Date | Transaction | Cost | #Shares | Value ($) | #Shares Total |
|---|---|---|---|---|---|---|---|
| O'Toole David D | CFO |
Aug 26 '25 |
Buy |
4.52 |
2,000 |
9,040 |
31,657 |
| McNamara Robert | Director |
Aug 19 '25 |
Buy |
5.00 |
10,000 |
50,000 |
76,771 |
| O'Toole David D | CFO |
Aug 12 '25 |
Buy |
4.81 |
2,000 |
9,620 |
29,657 |
| McNamara Robert | Director |
Mar 06 '25 |
Buy |
8.30 |
11,000 |
91,300 |
56,749 |
| McNamara Robert | Director |
Feb 20 '25 |
Buy |
10.09 |
10,000 |
100,900 |
45,749 |
| O'Toole David D | CFO |
Feb 20 '25 |
Buy |
9.90 |
1,000 |
9,900 |
25,734 |
| O'Toole David D | CFO |
Feb 19 '25 |
Buy |
10.25 |
1,000 |
10,250 |
24,734 |
| Crowe Suzanne | Director |
Dec 09 '24 |
Buy |
13.15 |
486 |
6,391 |
36,912 |
| O'Toole David D | CFO |
Dec 05 '24 |
Buy |
12.46 |
975 |
12,152 |
23,734 |
2.19%
0.50%
Open in Yahoo
|
Open in Google
|
Open in Finviz
|
Open in MarketWatch
|
Open in EDGAR
|
Open in Reuters
Cap:
|
Volume (24h):